To include your compound in the COVID-19 Resource Center, submit it here.

Arena gains on lorcaserin data

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) gained $0.18 (14%) to $1.45 after reporting with partner Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) a re-adjudication of female rat mammary tumor diagnoses

Read the full 260 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE